Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy.
Mitra S, Jang HJ, Kuncheria A, Kang SW, Choi JM, Shim JS, Lee C, Ranchod P, Jindra P, Ramineni M, Patel M, Ripley RT, Groth SS, Blackmon SH, Burt BM, Lee HS.
Mitra S, et al. Among authors: choi jm.
J Thorac Cardiovasc Surg. 2024 Oct 10:S0022-5223(24)00914-0. doi: 10.1016/j.jtcvs.2024.10.005. Online ahead of print.
J Thorac Cardiovasc Surg. 2024.
PMID: 39395787